106 related articles for article (PubMed ID: 18523235)
1. Effects of cerivastatin withdrawal on statin persistence.
Reaume KT; Erickson SR; Dorsch MP; Dunham NL; Hiniker SM; Prabhakar N; Kline-Rogers EM; Eagle KA
Ann Pharmacother; 2008 Jul; 42(7):956-61. PubMed ID: 18523235
[TBL] [Abstract][Full Text] [Related]
2. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
[TBL] [Abstract][Full Text] [Related]
3. The cerivastatin withdrawal crisis: a "post-mortem" analysis.
Maggini M; Raschetti R; Traversa G; Bianchi C; Caffari B; Da Cas R; Panei P
Health Policy; 2004 Aug; 69(2):151-7. PubMed ID: 15212862
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
5. Adherence to medications by patients after acute coronary syndromes.
Sud A; Kline-Rogers EM; Eagle KA; Fang J; Armstrong DF; Rangarajan K; Otten RF; Stafkey-Mailey DR; Taylor SD; Erickson SR
Ann Pharmacother; 2005 Nov; 39(11):1792-7. PubMed ID: 16204391
[TBL] [Abstract][Full Text] [Related]
6. Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin.
Mantel-Teeuwisse AK; Klungel OH; Egberts TC; Verschuren WM; Porsius AJ; de Boer A
Drug Saf; 2004; 27(1):63-70. PubMed ID: 14720086
[TBL] [Abstract][Full Text] [Related]
7. Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.
Danchin N; Diévart F; Thébaut JF; Grenier O; Mihci E; Herrmann MA; Ferrières J
Int J Cardiol; 2009 Mar; 133(1):32-40. PubMed ID: 18375000
[TBL] [Abstract][Full Text] [Related]
8. Long-term persistence with statin therapy: a nationwide register study in Finland.
Helin-Salmivaara A; Lavikainen P; Korhonen MJ; Halava H; Junnila SY; Kettunen R; Neuvonen PJ; Martikainen JE; Ruokoniemi P; Saastamoinen LK; Virta L; Huupponen R
Clin Ther; 2008; 30 Pt 2():2228-40. PubMed ID: 19281917
[TBL] [Abstract][Full Text] [Related]
9. Mapping geographic areas of high and low drug adherence in patients prescribed continuing treatment for acute coronary syndrome after discharge.
Hoang C; Kolenic G; Kline-Rogers E; Eagle KA; Erickson SR
Pharmacotherapy; 2011 Oct; 31(10):927-33. PubMed ID: 21950639
[TBL] [Abstract][Full Text] [Related]
10. [Concomitant use of statins and cytochrome P 450 inhibitors in Croatia].
Reiner Z; Galić M; Hanzevacki M; Tedeschi-Reiner E
Lijec Vjesn; 2005; 127(3-4):65-8. PubMed ID: 16193855
[TBL] [Abstract][Full Text] [Related]
11. The effect of switching on compliance and persistence: the case of statin treatment.
Thiebaud P; Patel BV; Nichol MB; Berenbeim DM
Am J Manag Care; 2005 Nov; 11(11):670-4. PubMed ID: 16268750
[TBL] [Abstract][Full Text] [Related]
12. In-hospital management and mortality in elderly patients with non-ST-segment elevation acute coronary syndromes treated in centers without on-site invasive facilities.
Dziewierz A; Siudak Z; Rakowski T; Zdzienicka J; Dykla D; Mielecki W; Dubiel JS; Dudek D
Cardiol J; 2008; 15(5):451-7. PubMed ID: 18810721
[TBL] [Abstract][Full Text] [Related]
13. Impact of duty hours restrictions on quality of care and clinical outcomes.
Bhavsar J; Montgomery D; Li J; Kline-Rogers E; Saab F; Motivala A; Froehlich JB; Parekh V; Del Valle J; Eagle KA
Am J Med; 2007 Nov; 120(11):968-74. PubMed ID: 17976424
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
Zhao SP; Peng DQ; Yu BL; Huo Y;
Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
[TBL] [Abstract][Full Text] [Related]
16. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
[TBL] [Abstract][Full Text] [Related]
17. Prognostic interactions between statins and in-hospital revascularisation on the outcome of acute coronary syndrome.
Wong CK; Tang EW; Herbison P
Heart Lung Circ; 2009 Aug; 18(4):262-5. PubMed ID: 19167924
[TBL] [Abstract][Full Text] [Related]
18. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
19. [Withdrawal of cerivastatin revealed a flaw of post-marketing surveillance system in the United States].
Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):41-5. PubMed ID: 16541751
[TBL] [Abstract][Full Text] [Related]
20. Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease.
Wald DS; Morton G; Walker K; Iosson N; Curzen NP
Ann Pharmacother; 2007 Oct; 41(10):1644-7. PubMed ID: 17785612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
